Therapeutic agents
US9358222B2 · kind B2 · utility
9Cited by
12References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 20, 2013 |
| Grant date | Jun 7, 2016 |
| Priority date | — |
| Expiry date | Nov 20, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula (I) or a compound of formula (II) or pharmaceutically acceptable salts thereof, wherein R1-R7 and X are as defined in the description, and the use of these compounds in therapy, in particular in treating cancer or as an inhibitor of the interaction of the MDM2 protein with p53.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.